[go: up one dir, main page]

WO2010082212A3 - N-biphenylacyl thiazolidine-2,4-dione derivatives, their synthesis and uses - Google Patents

N-biphenylacyl thiazolidine-2,4-dione derivatives, their synthesis and uses Download PDF

Info

Publication number
WO2010082212A3
WO2010082212A3 PCT/IN2009/000351 IN2009000351W WO2010082212A3 WO 2010082212 A3 WO2010082212 A3 WO 2010082212A3 IN 2009000351 W IN2009000351 W IN 2009000351W WO 2010082212 A3 WO2010082212 A3 WO 2010082212A3
Authority
WO
WIPO (PCT)
Prior art keywords
substituted
alkyl
linear
branched alkyl
chemical bond
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IN2009/000351
Other languages
French (fr)
Other versions
WO2010082212A2 (en
Inventor
Rajiv Sakhardande
Vithal Kulkarni
Narsingh Sachan
Manmohan Nimbalkar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Elder Pharmaceuticals Ltd
Original Assignee
Elder Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elder Pharmaceuticals Ltd filed Critical Elder Pharmaceuticals Ltd
Publication of WO2010082212A2 publication Critical patent/WO2010082212A2/en
Anticipated expiration legal-status Critical
Publication of WO2010082212A3 publication Critical patent/WO2010082212A3/en
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/4261,3-Thiazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

N- Biphenylacyl — thiazolidine-2,4-dione derivatives of the general formula (I); where in, Z1 and Z2 represent H, or together forms a chemical bond; R1 represents H, alkoxy, nitro, halo, hydroxy, optionally substituted amino group, - O-(CH2)n-N(R7)(R8), -O-(CH2)n-R9, wherein n is 0 to 5, -COOH, -CN, linear or branched alkyl, substituted alkyl, cycloalkyl, -S-R11 alkyl thio, acyl, aroyl, substituted or unsubstituted heterocyclic, alkoxy carbonyl, aryloxy, aryloxy carbonyl; R2 represents H, halo, hydroxy, linear or branched alkyl, substituted alkyl; R3, R4, R5 independently represents H, alkoxy, hydroxy, linear or branched alkyl, substituted alkyl; R6 represents H, -COOH, linear or branched alkyl, -CN, -SO3H, optionally substituted amino group; R7 represents H, linear or branched alkyl, cyclo alkyl, acyl, aroyl, aralkyl where in aryl moiety is substituted or unsubstituted, or an aryl; R8 represents a substituted or unsubstituted heterocyclic, linear or branched alkyl, substituted alkyl; R9 represents a substituted or unsubstituted heterocyclic, substituted or unsubstituted aromatic, substituted or unsubstituted cycloalkyl, fused arylheterocyclyl; when R1 represents alkoxy group, and Z1 and Z2 together forms a chemical bond then, R2 or R3 or R4 or R5 is other than H, and when R1, R2, R3, R4, R5 are each independently represents H, and Z1 and Z2 together forms a chemical bond then R6 is not H; And when R1, R2, R3, R4, R5 represents independently or together halo group and - Z1 and Z2 together forms a chemical bond, then R6 is not H; are novel compounds, their isomers and their enantiomers and their pharmaceutically acceptable salts or solvates and their pharmaceutical compositions containing such compounds and the use of such compounds and compositions in medicines and process for preparing the same.
PCT/IN2009/000351 2008-06-23 2009-06-18 N-biphenylacyl thiazolidine-2,4-dione derivatives, their synthesis and uses Ceased WO2010082212A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1299MU2008 2008-06-23
IN1299/MUM/2008 2008-06-23

Publications (2)

Publication Number Publication Date
WO2010082212A2 WO2010082212A2 (en) 2010-07-22
WO2010082212A3 true WO2010082212A3 (en) 2011-01-27

Family

ID=42340172

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2009/000351 Ceased WO2010082212A2 (en) 2008-06-23 2009-06-18 N-biphenylacyl thiazolidine-2,4-dione derivatives, their synthesis and uses

Country Status (1)

Country Link
WO (1) WO2010082212A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012041253A1 (en) * 2010-09-30 2012-04-05 Zhejiang Beta Pharma Inc. Compounds for increase of hdl-c level and uses thereof
CN104744388A (en) * 2015-03-03 2015-07-01 佛山市赛维斯医药科技有限公司 PTP1B inhibitor containing tetrazole structure, preparation method of PTP1B inhibitor and use of PTP1B inhibitor
CN104744387A (en) * 2015-03-03 2015-07-01 佛山市赛维斯医药科技有限公司 PTP1B inhibitor containing tetrazole and halobenzene structures, preparation method of PTP1B inhibitor and use of PTP1B inhibitor
CN105315223B (en) * 2015-11-06 2017-08-25 河南大学 A kind of high three-dimensional and high enantioselectivity thiazolidine dione compounds, its preparation method and application
WO2019016826A1 (en) * 2017-07-17 2019-01-24 Guru Ghasidas Vishwavidyalaya (A Central University) Novel 5-[4-(2-biphenyl-4-yl-2-oxo-ethoxy)-benzylidene]-thiazolidine-2,4-diones, their synthesis and uses thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005026127A1 (en) * 2003-09-11 2005-03-24 Institute Of Medicinal Molecular Design. Inc. Plasminogen activator inhibitor-1 inhibitor
BRPI0601826A (en) * 2006-03-24 2007-11-27 Univ Fed Pernambuco thiazolidinedinic compounds with hypoglycemic activity

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005026127A1 (en) * 2003-09-11 2005-03-24 Institute Of Medicinal Molecular Design. Inc. Plasminogen activator inhibitor-1 inhibitor
BRPI0601826A (en) * 2006-03-24 2007-11-27 Univ Fed Pernambuco thiazolidinedinic compounds with hypoglycemic activity

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
ANNALES PHARMACEUTIQUES FRANCAISES, vol. 51, no. 6, 1993, pages 283 - 291 *
DATABASE CAPLUS DE LIMA, J. G. ET AL.: "Quantitative structure-hypoglycemic activity relation of some substituted thiazolidine- and imidazolidine-2,4- diones", Database accession no. 1994:152973 *
DATABASE CAPLUS GILDO DE LIMA, JOSE ET AL.: "Electron impact mass spectra of 3- phenacyl-5-benzylidenethiazolidine-2,4-dione and -imidazolidine- 2,4-dione compounds", accession no. STN Database accession no. 1994:243873 *
SPECTROSCOPY, vol. 11, no. 1-6, 1993, pages 45 - 53 *

Also Published As

Publication number Publication date
WO2010082212A2 (en) 2010-07-22

Similar Documents

Publication Publication Date Title
IL161559A0 (en) Dibenzylamine derivatives and pharmaceutical compositions containing the same
WO2008010048A3 (en) Novel 2-substituted methyl penam derivatives
WO2005095409A3 (en) Tetrahydroquinoline derivatives and a process for preparing the same
ATE73797T1 (en) HETEROCYCLICALLY SUBSTITUTED INDOLES, INTERMEDIATE PRODUCTS, PROCESSES FOR THEIR MANUFACTURE AND PHARMACEUTICALS.
WO2008115098A3 (en) Substituted 2,3,4,5-tetrahydro-1h-pyrido[4,3-b]indoles, methods for the production and the use thereof
MY140528A (en) Spiroketal derivatives and their use as therapeutic agents for diabetes
WO2008081096A3 (en) Quinolinyl derivatives, method for preparing same, pharmaceutic compositions containing same, and use thereof as hypoglycemiant and hypolipemiant agents
MY141245A (en) Macrocylic inhibitors of hepatitis c virus
MY139887A (en) Tetrahydronaphthyridine derivatives and a process for preparing the same.
NO20076006L (en) acetylene Derivatives
MX2009003927A (en) Thioglucose spiroketal derivative and use thereof as therapeutic agent for diabetes.
WO2010033643A3 (en) Small molecule compounds for stem cell differentiation
WO2021008588A9 (en) Class of pyrimidine quinoline derivatives and preparation method therefor and application thereof
WO2010082212A3 (en) N-biphenylacyl thiazolidine-2,4-dione derivatives, their synthesis and uses
IL183373A0 (en) 3-[2-(3-acylamino-2-oxo-2h-pyridin-1-yl)-acetylamino]-4-oxo-pentanoic acid derivatives, pharmaceutical compositions containing the same and methods for the preparation thereof
IN2012DN00770A (en)
WO2006071471A3 (en) 2-(2 or 4-substituted aryloxy)-phenol derivatives as antibacterial agents
WO2008049997A3 (en) Indole derivatives, process for the preparation thereof and pharmaceutical compositions containing them
WO2010139967A8 (en) Dihydroindole and tetrahydroisoquinoline derivatives useful as potassium channel inhibitors
WO2009019721A3 (en) Quercetin derivatives as anti-cancer agents
WO2002083649A1 (en) Novel imidazolidinedione derivatives and use thereof as drugs
ATE165362T1 (en) NEW DERIVATIVES OF 2-(1H)-QUINOLINONE, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING THEM
WO2008120661A1 (en) Novel fused pyrrole derivative
MY139011A (en) Piperazine compounds, a process for their preparation and pharmaceutical compositions containing them
WO2004024735A3 (en) A new process for the preparation of epothilone derivatives, new epothilone derivatives as well as new intermediate products for the process and the methods of preparing same

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09838192

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09838192

Country of ref document: EP

Kind code of ref document: A2